Skip to content
PeptideRank
Direct Meds logo

Provider review

Direct Meds cost: $399/mo tirzepatide

Flat prices on all three compounds, no pharmacy named, and an open FDA letter.

Direct Meds prints one flat price per product — $399/mo tirzepatide, $297/mo semaglutide, $199/mo sermorelin (sold as "Sermorix") — each sitting next to "No Monthly Memberships, No Hidden Fees, Cancel Anytime." No pharmacy is named anywhere, and the site has no Terms of Service page at all.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What Direct Meds discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Not disclosed

Does not name a pharmacy or state a regulatory category anywhere on its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Disclosed

The advertised price is the ongoing price — no prepay or auto-refill required to unlock it.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit Direct Meds

Pharmacy

Not categorized

Labs

Not stated.

States

Not published

On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Included

Shipping

Not confirmed

Lab work

Not disclosed

Coaching

Not confirmed

See plans at Direct Meds

Prices read from Direct Meds's own site · August 2026

What they advertise

One flat figure per product: "$399/month, $9.58 per day" for tirzepatide, "$297/month, $9.58 per day" for semaglutide, and "$199/month, $6.42 per day" for sermorelin ("Sermorix") — each printed beside "No Monthly Memberships, No Hidden Fees, Cancel Anytime."

What you actually pay

$399 for tirzepatide, $297 for semaglutide and $199 for sermorelin are the standing prices on every product page — no separate one-time purchase, no prepay tier, no auto-refill discount underneath them. The FAQ mentions a lower figure for a "sublingual Semaglutide" that has no product page of its own, so treat that one as unconfirmed.

The bottom line

Direct Meds (directmeds.com) sells compounded tirzepatide, compounded semaglutide and compounded sermorelin — the last under its own brand name, "Sermorix" — alongside a wider non-GLP-1 catalog. The pricing is genuinely clean for this category: one flat monthly figure per product page, matching its FAQ, with a repeated no-subscription claim and no prepay tier or auto-refill hiding underneath. What drags it down is everything around the price. No pharmacy is named on any page, only "licensed compounding pharmacy"; there is no states-served list; and there is no public Terms of Service anywhere, which is odd for a company whose FAQ claims 250,000+ patients. FDA also issued DirectMeds.com, Inc. a warning letter (MARCS-CMS #716822, September 9, 2025) over marketing that equated compounded GLP-1s with FDA-approved drugs, and no close-out letter has followed. One more thing worth saying out loud: the blog is broken. Every article URL serves the same unrelated "shift work" post — including the one titled "Meet the Pharmacy," which might otherwise have named a compounding partner.

Direct Meds appears on our sermorelin provider ranking, our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking and our combined weight loss injections ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You want one flat monthly price on the page — tirzepatide, semaglutide or sermorelin — with no quiz or account to get past first.
  • You've read FDA's warning letter and decided the marketing language it flagged doesn't change your decision.

Look elsewhere if

  • You want a pharmacy name or a 503A/503B category — Direct Meds publishes neither.
  • You want to confirm your state is served before starting an intake — there is no states list.
  • You read a company's Terms of Service before signing up — this one doesn't publish any.
  • An open FDA warning letter over how a company marketed compounded GLP-1s is a hard line for you, whatever has changed since.

What Direct Meds offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

Who fills your prescription

No category stated

Direct Meds does not name the pharmacy that fills your prescription.

What its own site says

Not one pharmacy is named — not on the homepage, not on any product page, not in the FAQ. The FAQ says only that it works with "fully licensed pharmacies" and that prescriptions are "compounded at a certified U.S. pharmacy." No name, no 503A or 503B category.

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Not published

There is no states-served list, and no exclusion list either. There is also no public Terms of Service page on the site, which is where a list like that usually lives.

The honest cons

The part they would rather you skipped

FDA issued DirectMeds.com, Inc. a warning letter (MARCS-CMS #716822, September 9, 2025) over marketing that equated compounded semaglutide and tirzepatide with FDA-approved products: "Compounded drug products are not FDA-approved. Your claims imply that your products are the same as an FDA-approved product when they are not," flagging language including "Compounded semaglutide contains the same active ingredient as branded semaglutide." There is still no close-out letter, roughly eleven months on. Several peers here carry the same class of finding, and it is not disqualifying on its own — but it stays on the record here, with its date.

  • Its own tirzepatide page prints "$399 /month" beside "$9.58 per day" — but $399 a month is about $12.87 a day. $9.58 is the per-day figure from its semaglutide page ($297). The daily number on the more expensive drug is wrong.
  • No pharmacy is named anywhere, and no 503A/503B category is stated for any product.
  • No states-served list is published.
  • No public Terms of Service exists anywhere on the site — an odd gap for a company whose FAQ claims 250,000+ patients.
  • The blog is broken: every article URL serves the same unrelated post, including one titled "Meet the Pharmacy" that might otherwise have named a compounding partner.

None of this is unique to Direct Meds — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Ready to get started?

Prices and plans in this category change often — check Direct Meds's current pricing before you decide. Ours was read from their own site in August 2026.

See Direct Meds pricing

Facts on this page reflect Direct Meds's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on Direct Meds's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.

Direct Meds

4 compounds from $199/mo

Visit